A quantitative biometrological assessment of acne and hormonal evaluation in young women using a triphasic low-dose oral contraceptive containing gestodene

REFERENCES

• Beylot C, Coutre M S, Beylot-Barry M. Oral contraceptives and cyproterone acetate in female acne treatment. Dermatology 1998; 196: 148–52
   PubMed Web of Science ®Google Scholar
• Gaspard U J. Role of antiandrogens in the treatment of acne. Dermatology 1998; 37: 369–94
   Google Scholar
• Rabe T, Grunwald K, Feldman K, et al. Treatment of hyperandrogenism in women. Gynecol Endocrinol 1996; 10(Suppl 3)1–44
   PubMedGoogle Scholar
• Spona J, Huber J. Pharmacological and endocrine profiles of gestodene. Int J Fertil 1987; 32: 6–14
   PubMedGoogle Scholar
• Rabe T, Runnebaum B, Kohlmeier M, et al. Clinical and metabolic effects of gestodene and levonorgestrel. Int J Fertil 1987; 32: 29–44
   PubMedGoogle Scholar
• Beier S, Syeinback H, Schillinger E, . Gynecological Endocrinology, A R Genazzani, A Volpe, F Facchinetti, et al. Parthenon Publishing Group, Carnforth, UK 1987; 477–93
   Google Scholar
• Rabe T, Runnebaum B, Unger R, . Gynecological Endocrinology, A R Genazzani, A Volpe, F Facchinetti, et al. Parthenon Publishing Group, Carnforth, UK 1987; 503–16
   Google Scholar
• Weber-Diehl F, Unger R, Lachnit U. Triphasic combination of ethinyl estradiol and gestodene. Long-term clinical trial. Contraception 1992; 46: 19–27
   PubMed Web of Science ®Google Scholar
• Piérard G E, Nikkels-Tassoudji N, Goffin V, et al. Acne improvement in young women using a low-dose triphasic oral contraceptive containing gestodene and ethinylestradiol (Tri-Minulet®). Interim evaluation of an open non-controlled clinical study combined with objective biometrological methods. Gynecol Endocrinol 1996; 10(Suppl 5)61–6
   Google Scholar
• Woutersz T B, Korba V D. Five-year, multicenter study of a triphasic, low-dose, combination oral contraceptive. Int J Fertil 1988; 33: 406–10
   PubMedGoogle Scholar
• Lemay A, Dewailly S D, Grenier R, et al. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethinyl estradiol and d,l-norgestrel. J Clin Endocrinol Metab 1990; 71: 8–14
   PubMed Web of Science ®Google Scholar
• Mills O H, Jr., Kligman A M. The follicular biopsy. Dermatologica 1983; 167: 57–63
   PubMedGoogle Scholar
• Letawe C, Boone M, Piérard G E. Digital image analysis of the effect of topically applied linoleic acid on acne microcomedones. Clin Exp Dermatol 1998; 23: 56–8
   PubMed Web of Science ®Google Scholar
• Piérard G E, Piérard-Franchimont C, Goffin V. Digital image analysis of microcomedones. Dermatology 1995; 190: 99–103
   PubMed Web of Science ®Google Scholar
• Piérard-Franchimont C, Piérard G E. Cosmetics: Controlled Efficacy studies and Regulation, P Elsner, H I Maibach, H F Merk. Springer-Verlag, Berlin 1999; 268–74
   Google Scholar
• McGinley K J, Webster G F, Leyden J J. Facial follicular porphyrin fluorescence: correlation with age and density of Propionibacterium acnes. Br J Dermatol 1980; 102: 437–41
   PubMed Web of Science ®Google Scholar
• Sauermann G, Ebens B, Hoppe U. Analysis of facial comedos by porphyrin fluorescence and image analysis. J Toxicol - Cutaneous Ocular Toxicol 1990; 9: 369–85
   Google Scholar
• Arrese J E, Goffin V, Avila-Camacho M, et al. A pilot study on bacterial viability in acne. Assessment using dual flow cytometry on microbials present in follicular casts and comedones. Int J Dermatol 1998; 37: 461–4
   PubMed Web of Science ®Google Scholar
• Piérard G E, Piérard-Franchimont C. Seborrhoea in acne-prone and acne-free patients. Dermatologica 1987; 175: 5–9
   PubMedGoogle Scholar
• Piérard-Franchimont C, Piérard G E, Kligman A M. Rhythm of sebum excretion during the menstrual cycle. Dermatologica 1991; 182: 211–13
   PubMedGoogle Scholar
• Piérard-Franchimont C, Piérard G E, Saint-Léger D, et al. Comparison of the kinetics of sebum secretion in young women with and without acne. Dermatologica 1991; 183: 120–2
   PubMedGoogle Scholar
• Pochi P E, Shalita A R, Strauss J S, et al. Report of the Consensus Conference on Acne Classification, Washington, DC, 24–25 March 1990. J Am Acad Dermatol 1991; 24: 495–500
   PubMed Web of Science ®Google Scholar
• Cunliffe W J. The sebaceous gland and acne – 40 years on. Dermatology 1998; 196: 9–15
   PubMed Web of Science ®Google Scholar
• Lucky A W, Rosenfield R L, McGuire J, et al. Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche. J Clin Endocrinol Metab 1986; 62: 840–8
   PubMed Web of Science ®Google Scholar
• Slayden S M, Azziz R. Androgen Excess Disorders in Women, R Azziz, J E Nestler, D Dewailly. Lippincott-Raven, Philadelphia, PA 1997; 131–40
   Google Scholar
• Lookingbill D P, Horton R, Demers L M, et al. Tissue production of androgens in women with acne. J Am Acad Dermatol 1985; 12: 481–7
   PubMed Web of Science ®Google Scholar
• Vermeulen A, Rubens R. Effects of cyproterone acetate plus ethinylestradiol low dose on plasma androgens and lipids in mildly hirsute or acneic young women. Contraception 1988; 38: 419–28
   PubMed Web of Science ®Google Scholar
• Rantala M-L, Stenman U H, Koskimies A I. Serum androgens in infertile women with ovulatory dysfunction. Hum Reprod 1988; 3: 437–9
   PubMed Web of Science ®Google Scholar
• Jung-Hoffmann C, Heidt F, Kuhl H. Effect of two oral contraceptives containing 30 micrograms ethinylestradiol and 75 micrograms gestodene or 150 micro-grams desogestrel upon various hormonal parameters. Contraception 1988; 38: 593–603
   PubMed Web of Science ®Google Scholar
• Lepot M R, Gaspard U J, Dubois E, . Triphasic Gestodene, A R Genazzani, S O Skouby, et al. Parthenon Publishing Group, Carnforth, UK 1992; 43–54
   Google Scholar
• Brill K, Schnitker J, Albring M. Clinical experience with a modern low-dose gestodene-containing oral contraceptive in adolescents. Adv Contracept 1994; 10: 237–47
   PubMedGoogle Scholar
• Rabe T, Maletz-Kehry W, Leppien G, et al. Clinical update on triphasic gestodene. Gynecol Endocrinol 1993; 7(Suppl)25–32
   Google Scholar
• Andrade R P. Clinical comparison of a triphasic gestodene preparation and a monophasic desogestrel preparation. Gynecol Endocrinol 1993; 7(Suppl)33–41
   PubMed Web of Science ®Google Scholar